France· FR:60931882
LEVOFREE 0,05 %, collyre en solution
A medicinal product containing chlorhydrate de lévocabastine, registered in France by LABORATOIRE CHAUVIN, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE LÉVOCABASTINE
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301459511 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) avec fermeture à témoin d'effraction de 5 mLEUR 5.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de lévocabastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyLevocabastinDermapharm Ag
- United KingdomLivostin 0.05% nasal sprayNovartis Pharmaceuticals UK Ltd
- SwedenLivocab 50 mikrogram/dos Nässpray, suspensionOrifarm AB
- FinlandLivostinParanova Oy
- BelgiumLivostin 0.5 mg/mlKenvue Belgium
- NorwayLivostinMcNeil Sweden AB
- IcelandLivostinMcNeil Sweden AB
- SpainBILINA 0,5 mg/ml COLIRIO EN SUSPENSIÓNEsteve Pharmaceuticals S.A.
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Levocamed, Livostin
- Belgium · Livostin, Nasasinuspray Anti-Allergie
- Czechia · Livostin
- Germany · Levocabastin, Levocamed
- Denmark · Benaliv
- Spain · Bilina, Reactine
- Finland · Livostin
- Greece · Livostin
- Iceland · Livostin
- Italy · Levoreact, Levoreact Oftalmico
- Luxembourg · Livostin, Nasasinuspray Anti-Allergie
- Netherlands · Livocab
- Norway · Livostin
- Sweden · Livostin
- Slovakia · Livostin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af2833ae-d468-4eef-a38f-408080f61538 GET /v1/drugs/af2833ae-d468-4eef-a38f-408080f61538?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60931882",
"date_amm": "2018-05-14",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE LÉVOCABASTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de lévocabastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.